352 results
Page 2 of 18
8-K
EX-99.1
bzozb mshqc8lwdstkf
11 Aug 22
LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
8-K
EX-99.1
t2mgu2g
12 May 22
LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
8-K
EX-99.1
ybf y1r129
11 May 22
Regulation FD Disclosure
7:54pm
8-K
EX-99.1
q0ciwpbt
10 Mar 22
LINEAGE CELL THERAPEUTICS REPORTs FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:10pm
424B5
asv38uok9twn k0jjub9
21 Dec 21
Prospectus supplement for primary offering
6:05am
8-K
EX-99.1
pqhe gwbg74fz
20 Dec 21
Entry into a Material Definitive Agreement
6:06am
8-K
EX-99.1
q56eomf1
13 Dec 21
Regulation FD Disclosure
4:10pm
8-K
EX-99.1
wu8p74
10 Nov 21
LINEAGE REPORTs THIRD QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS PROGRESS FROM CLINICAL CELL THERAPY PROGRAMS
4:10pm
8-K
EX-99.1
eixg6z
30 Sep 21
Regulation FD Disclosure
5:29pm
8-K
EX-99.1
aj7l qwvo8p4o
12 Aug 21
LINEAGE REPORTs SECOND QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS ADDITIONAL PROGRESS FROM CLINICAL CELL THERAPY PROGRAMS
4:10pm
8-K
EX-99.1
s74pm9pjl6 j1qg0
1 Jun 21
Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration In Dry Amd Patients Treated with OpregenĀ® Rpe Cells
7:00am
8-K
EX-99.1
9gnvhd
13 May 21
LINEAGE REPORTs FIRST QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS
4:10pm
8-K
EX-99.1
glhp9lhl20j8
3 May 21
OpREGENĀ® CLINICAL DATA CONTINUES TO DEMONSTRATE IMPROVEMENTS IN PATIENTS WITH DRY AMD WITH GEOGRAPHIC ATROPHY
5:00pm